Cardiovascular DiseaseBuilding on Our Strengths

• GLP-1 (continuous infusion)

  • Potential treatment for late-stage congestive heart failure
  • Phase 2 program - data expected mid-2003
  • Program acquired from Restoragen - pending bankruptcy approval

• AC3056

  • Potential treatment for atherosclerosis
  • Phase 1 program ongoing

Previous slide

Next slide

Back to first slide

View graphic version